217 related articles for article (PubMed ID: 23855306)
1. Immunocompetent nontransgenic mouse models for studying hepatitis B virus immune responses.
Tzeng HT; Hsu PN; Chen PJ
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():116-9. PubMed ID: 23855306
[TBL] [Abstract][Full Text] [Related]
2. Sequential control of hepatitis B virus in a mouse model of acute, self-resolving hepatitis B.
von Freyend MJ; Untergasser A; Arzberger S; Oberwinkler H; Drebber U; Schirmacher P; Protzer U
J Viral Hepat; 2011 Mar; 18(3):216-26. PubMed ID: 20367794
[TBL] [Abstract][Full Text] [Related]
3. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection.
Huang LR; Wu HL; Chen PJ; Chen DS
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17862-7. PubMed ID: 17095599
[TBL] [Abstract][Full Text] [Related]
4. A murine model of hepatitis B-associated hepatocellular carcinoma generated by adeno-associated virus-mediated gene delivery.
Huang YH; Fang CC; Tsuneyama K; Chou HY; Pan WY; Shih YM; Wu PY; Chen Y; Leung PS; Gershwin ME; Tao MH
Int J Oncol; 2011 Dec; 39(6):1511-9. PubMed ID: 21805030
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection.
Wang Z; Zhu K; Bai W; Jia B; Hu H; Zhou D; Zhang X; Zhang X; Xie Y; Bourgine MM; Michel ML; Lan K; Deng Q
J Virol; 2014 Mar; 88(5):3004-15. PubMed ID: 24371056
[TBL] [Abstract][Full Text] [Related]
6. Adeno-Associated Virus Vector Mediated Delivery of the HBV Genome Induces Chronic Hepatitis B Virus Infection and Liver Fibrosis in Mice.
Ye L; Yu H; Li C; Hirsch ML; Zhang L; Samulski RJ; Li W; Liu Z
PLoS One; 2015; 10(6):e0130052. PubMed ID: 26075890
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.
Ren S; Nassal M
J Virol; 2001 Feb; 75(3):1104-16. PubMed ID: 11152483
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance.
Lan P; Zhang C; Han Q; Zhang J; Tian Z
Hepatology; 2013 Jul; 58(1):73-85. PubMed ID: 23447417
[TBL] [Abstract][Full Text] [Related]
9. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
[TBL] [Abstract][Full Text] [Related]
10. [Immunosuppressant dexamethasone can significantly extend the expression of hepatitis B virus antigens in the HBV mouse model by hydrodynamic transfection method].
Guo YJ; Wang W; Sun SH; Zeng DB; Zhao GY; Yu H; Guo Y; Tan WJ; Lu SC; Zhou YS
Bing Du Xue Bao; 2010 Jan; 26(1):20-6. PubMed ID: 20329554
[TBL] [Abstract][Full Text] [Related]
11. Transfer of HBV genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice.
Huang LR; Gäbel YA; Graf S; Arzberger S; Kurts C; Heikenwalder M; Knolle PA; Protzer U
Gastroenterology; 2012 Jun; 142(7):1447-50.e3. PubMed ID: 22426294
[TBL] [Abstract][Full Text] [Related]
12. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
[TBL] [Abstract][Full Text] [Related]
13. [Establishment of hepatitis B virus (HBV) chronic infection mouse model by in vivo transduction with a recombinant adeno-associated virus 8 carrying 1. 3 copies of HBV genome (rAAN8-1. 3HBV)].
Dong XY; Yu CJ; Wang G; Tian WH; Lu Y; Zhang FW; Wang W; Wang Y; Tan WJ; Wu XB
Bing Du Xue Bao; 2010 Nov; 26(6):425-31. PubMed ID: 21344744
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus as a gene delivery vector activating foreign antigenic T cell response that abrogates viral expression in mouse models.
Deng Q; Mancini-Bourgine M; Zhang X; Cumont MC; Zhu R; Lone YC; Michel ML
Hepatology; 2009 Nov; 50(5):1380-91. PubMed ID: 19821533
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus sensitizes hepatocytes to complement-dependent cytotoxicity through downregulating CD59.
Qu Z; Liang X; Liu Y; Du J; Liu S; Sun W
Mol Immunol; 2009 Dec; 47(2-3):283-9. PubMed ID: 19804910
[TBL] [Abstract][Full Text] [Related]
16. Recognition of HBV antigens and HBV DNA by dendritic cells.
Cui GY; Diao HY
Hepatobiliary Pancreat Dis Int; 2010 Dec; 9(6):584-92. PubMed ID: 21134826
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes.
Kondo Y; Ueno Y; Kobayashi K; Kakazu E; Shiina M; Inoue J; Tamai K; Wakui Y; Tanaka Y; Ninomiya M; Obara N; Fukushima K; Ishii M; Kobayashi T; Niitsuma H; Kon S; Shimosegawa T
J Infect Dis; 2010 Jul; 202(2):202-13. PubMed ID: 20533879
[TBL] [Abstract][Full Text] [Related]
18. Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA.
Chen CC; Ko TM; Ma HI; Wu HL; Xiao X; Li J; Chang CM; Wu PY; Chen CH; Han JM; Yu CP; Jeng KS; Hu CP; Tao MH
Gene Ther; 2007 Jan; 14(1):11-9. PubMed ID: 16929350
[TBL] [Abstract][Full Text] [Related]
19. Use of RNA interference to modulate liver adenoma development in a murine model transgenic for hepatitis B virus.
Chen CC; Chang CM; Sun CP; Yu CP; Wu PY; Jeng KS; Hu CP; Chen PJ; Wu JC; Shih CH; Gershwin ME; Tao MH
Gene Ther; 2012 Jan; 19(1):25-33. PubMed ID: 21562593
[TBL] [Abstract][Full Text] [Related]
20. The immune response induced by hepatitis B virus principal antigens.
Huang CF; Lin SS; Ho YC; Chen FL; Yang CC
Cell Mol Immunol; 2006 Apr; 3(2):97-106. PubMed ID: 16696896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
